Staying Ahead of the Curve in Biopharma: Navigating FDA Inspections, Drug Supply Chain Security Act (DSCSA) Implementation, and Supply Chain Disruptions
FDA inspections of biopharmaceutical manufacturers often lead to the discovery of avoidable compliance issues.